Potent, selective CysLT1 (LTD4) leukotriene receptor antagonist (IC50 = 6.4 nM). Inhibits LTD4-induced bronchoconstriction in guinea pigs when administered intravenously, orally or by aerosol.
|Storage||Desiccate at -20°C|
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
All Tocris products are intended for laboratory research use only.
|Solvent||Max Conc. mg/mL||Max Conc. mM|
Preparing Stock Solutions
The following data is based on the product molecular weight 412.55. Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.
|Concentration / Solvent Volume / Mass||1 mg||5 mg||10 mg|
|1 mM||2.42 mL||12.12 mL||24.24 mL|
|5 mM||0.48 mL||2.42 mL||4.85 mL|
|10 mM||0.24 mL||1.21 mL||2.42 mL|
|50 mM||0.05 mL||0.24 mL||0.48 mL|
References are publications that support the products' biological activity.
O'Donnell (1991) Ro 24-5913: a potent, specific, orally active LTD4 antagonist. Ann.N.Y.Acad.Sci. 629 413 PMID: 1659286
O'Donnell et al (1991) Pharmacologic actions of Ro 24-5913, a novel antagonist of leukotriene D4. J.Pharmacol.Exp.Ther. 259 751 PMID: 1658310
If you know of a relevant reference for Cinalukast, please let us know.
View Related Products by Target
View Related Products by Product Action
Keywords: Cinalukast, supplier, Potent, selective, CysLT1, LTD4, antagonists, orally, active, Receptors, LTE4, leukotrienes, eicosanoids, Ro245913, Ro, 24-5913, Leukotriene, and, Related, Receptors, Leukotriene, and, Related, Receptors, Tocris Bioscience
Citations for Cinalukast
Citations are publications that use Tocris products.
Currently there are no citations for Cinalukast. Do you know of a great paper that uses Cinalukast from Tocris? If so please let us know.
Average Rating:(Based on 0 Reviews)